Short-term antidiabetic treatment with insulin or metformin has a similar impact on the components of metabolic syndrome in women with gestational diabetes mellitus requiring antidiabetic agents: Results of a prospective, randomised study

Journal of Physiology and Pharmacology

Volumn 67, Issue 2, 2016, Pages 227-233

  Zawiejska, Agnieszka ^a   Wender Ozegowska, E ^a   Grewling Szmit, K ^a   Brazert, M ^a   Brazert, J ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Atherogenic index of plasma; Diabetes; Glycated hemoglobin; Insulin; Lipids; Metformin; Obesity; Pregnancy

Indexed keywords

HEMOGLOBIN A1C; INSULIN; METFORMIN; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; LIPID;

ADULT; ANTIDIABETIC ACTIVITY; ARTICLE; ATHEROGENIC DIET; BODY MASS; CONTROLLED STUDY; DRUG DOSE TITRATION; EVALUATION AND FOLLOW UP; FEMALE; GESTATIONAL AGE; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; YOUNG ADULT; ANALYSIS; BLOOD; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; PREGNANCY;

ADULT; BLOOD GLUCOSE; DIABETES, GESTATIONAL; FASTING; FEMALE; GLYCATED HEMOGLOBIN A; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LIPIDS; METABOLIC SYNDROME; METFORMIN; PREGNANCY;

EID: 84971576465     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Linnenkamp U, Guariguata L, Beagley J, Whiting DR, Cho NH. The IDF Diabetes Atlas methodology for estimating global prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract 2014; 103: 186-196.
2. Desoye G, van Poppel M. The feto-placental dialogue and diabesity. Best Pract Res Clin Obstet Gynaecol 2015; 29: 15-23.
3. Mitanchez D, Yzydorczyk C, Siddeek B, Boubred F, Benahmed M, Simeoni U. The offspring of the diabetic mother - short- and long-term implications. Best Pract Res Clin Obstet Gynaecol 2015; 29: 256-269.
4. Diabetes and Pregnancy. Management of Diabetes and its Complications from Preconception to the Postnatal Period. NICE guideline 3 (NG3). National Collaborating Centre for Women’s and Children’s Health. National Institute for Health and Care Excellence. London and Manchester, 2015.
5. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2013; 37: S1-S212.
6. IDF Clinical Guidelines Task Force. Global Guideline on Pregnancy and Diabetes. Brussels, International Diabetes Federation, 2009.
7. Lautatzis ME, Goulis DG, Vrontakis M. Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review. Metabolism 2013; 62: 1522-1534.
8. Balsells M, Garcia-Patterson A, Sola I, Roque M, Gich I, Corcoy R. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ 2015; 350: h102. doi: 10.1136/bmj.h102.
9. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell punction from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
10. Schaefer EJ, Lamon-Fava S, Ordova JM, et al. Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. J Lipid Res 1994; 35: 871-882.
11. Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER). Clin Biochem 2001; 34: 583-588.
12. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity and gestational diabetes mellitus. Pediatrics 2005;115: e290-e296.
13. Bezpalko L, Gavriluk O, Zayachkivska O. Inflammatory response in visceral fat tissue and liver is prenatally programmed: experimental research. J Physiol Pharmacol 2015; 66: 57-64.
14. Ryckman KK, Spracklen CN, Smith CJ, Robinson JG, Saftlas AF. Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and metaanalysis. BJOG 2015; 122: 643-651.
15. Barrett HL, Dekkert Nitert M, Jones L, et al. Determinants of maternal triglycerides in women with gestational giabetes mellitus in the Metformin in Gestational Diabetes (MiG) Study. Diabetes Care 2013; 36: 1941-1946.
16. Gong L, Goswami S, Giacomini KM, Altman RB, Klein TE. Metformin pathways: pharmacokinetics and pharmaco-dynamics. Pharmacogenet Genomics 2012; 22: 820-827.
17. Viollet B, Guigas B, Garcia NS, Leclerc J, Foretz M, Andreelli F. Celullar and molecular mechanisms of metformin: an overview. Clin Sci (Lond) 2012; 122: 253-270.
18. Rena G, Pearson ER, Sakamoto K. Molecular mechanism of action of metformin: old or new insights. Diabetologia 2013; 56: 1898-1906.
19. Geerling JJ, Boon MR, van der Zon GC et al. Metformin lowers plasma triglycerides by promoting VLDL-triglyceride clearance by brown adipose tissue in mice. Diabetes 2014; 63: 880-891.
20. Kurzynska A, Bogacki M, Chojnowska K, Bogacka I. Peroxisome proliferator activated receptor ligands affect progresterone and 17β-estradiol secretion by porcine corpus luteum during early pregnancy. J Physiol Pharmacol 2014; 65: 709-717.
21. Raslova K, Dobiasova M, Hubacek JA, et al. Association of metabolic and genetic factors with cholesterol esterification wate in HDL plasma and atherogenic index of plasma in 40 years old Slovak population. Physiol Res 2011; 60: 785-795.
22. Dobiasova M. Atherogenic index of plasma [Log(Triglycerides/HDL-Cholesterol)]: theoretical and practical implications. Clin Chem 2004; 50: 1113-1115.
23. Zawiejska A, Wender-Ozegowska E, Brazert J, Sodowski K. Components of metabolic syndrome and their impact on fetal growth in women with gestational diabetes mellitus. J Physiol Pharmacol 2008; 59 (Suppl. 4): 5-18.
24. Iciek R, Wender-Ozegowska E, Mikolajczak P, et al. Placental vascular endothelial growth factor expression in pregnancies complicated by type 1 diabetes. J Physiol Pharmacol 2014; 65: 577-583.